Literature DB >> 27073454

Effect of vasopressin on hippocampal injury in a rodent model of asphyxial cardiopulmonary arrest.

Nan Zhang1, Xiu-Xian Zang1, Ning Dong1, Fang Liu1, Shao-Kun Wang1, H E Yan1, DA-Hai Xu1, Xiao-Liang Liu1, L I Pang1.   

Abstract

The effect of vasopressin on the neuronal injury following the restoration of spontaneous circulation (ROSC) in cardiac arrest (CA) is not yet fully understood. The present study was conducted in order to investigate the effect of vasopressin alone, or in combination with epinephrine, on the ROSC and hippocampal injury in a rat model of asphyxial CA. Asphyxial CA was induced in 144 rats by clamping the tracheal tube, and animals were allocated equally into the following three groups: Treatment with vasopressin (0.8 U/kg); epinephrine (0.2 mg/kg); or vasopressin (0.8 U/kg) plus epinephrine (0.2 mg/kg). An additional 48 rats underwent a sham surgical procedure without asphyxial CA and cardiopulmonary resuscitation. Hippocampal tissue was harvested at 1, 3, 6 and 12 h post-ROSC, and the levels of p38 mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) p65 were determined using immunohistochemistry. In comparison with rats treated with epinephrine alone, higher ROSC success rates were observed in rats treated with vasopressin, or vasopressin plus epinephrine. In addition, treatment with vasopressin attenuated hippocampal injury and reduced hippocampal p38 MAPK and NF-κB expression more efficiently compared with epinephrine alone. In conclusion, treatment with vasopressin exhibits a protective effect in patients experiencing CA, and this may be attributed to the inhibition of p38 MAPK and NF-κB expression.

Entities:  

Keywords:  asphyxial cardiopulmonary resuscitation; epinephrine; nuclear factor-κB; p38 mitogen-activated protein kinase; vasopressin

Year:  2016        PMID: 27073454      PMCID: PMC4812261          DOI: 10.3892/etm.2016.3028

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs.

Authors:  Karl H Stadlbauer; Horst G Wagner-Berger; Volker Wenzel; Wolfgang G Voelckel; Anette C Krismer; Günter Klima; Klaus Rheinberger; Sebastian Pechlaner; Viktoria D Mayr; Karl H Lindner
Journal:  Anesth Analg       Date:  2003-06       Impact factor: 5.108

2.  Advanced cardiac life support in out-of-hospital cardiac arrest.

Authors:  Ian G Stiell; George A Wells; Brian Field; Daniel W Spaite; Lisa P Nesbitt; Valerie J De Maio; Graham Nichol; Donna Cousineau; Josée Blackburn; Doug Munkley; Lorraine Luinstra-Toohey; Tony Campeau; Eugene Dagnone; Marion Lyver
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

3.  Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway.

Authors:  A C Maroney; M A Glicksman; A N Basma; K M Walton; E Knight; C A Murphy; B A Bartlett; J P Finn; T Angeles; Y Matsuda; N T Neff; C A Dionne
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

4.  Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury.

Authors:  Lin Xu; Yutian Zhan; Yibin Wang; Giora Z Feuerstein; Xinkang Wang
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

5.  Combination pharmacotherapy improves neurological outcome after asphyxial cardiac arrest.

Authors:  Giolanda Varvarousi; Elizabeth O Johnson; Sotirios Goulas; Georgios Agrogiannis; Nikolaos Valsamakis; Despina Perrea; Christodoulos Stefanadis; Lila Papadimitriou; Theodoros Xanthos
Journal:  Resuscitation       Date:  2011-10-01       Impact factor: 5.262

Review 6.  Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice.

Authors:  Toshinori Aoyagi; Taka-aki Koshimizu; Akito Tanoue
Journal:  Kidney Int       Date:  2009-08-19       Impact factor: 10.612

7.  Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation.

Authors:  Pierre-Yves Gueugniaud; Jean-Stéphane David; Eric Chanzy; Hervé Hubert; Pierre-Yves Dubien; Patrick Mauriaucourt; Coralie Bragança; Xavier Billères; Marie-Paule Clotteau-Lambert; Patrick Fuster; Didier Thiercelin; Guillaume Debaty; Agnès Ricard-Hibon; Patrick Roux; Catherine Espesson; Emgan Querellou; Laurent Ducros; Patrick Ecollan; Laurent Halbout; Dominique Savary; Frédéric Guillaumée; Régine Maupoint; Philippe Capelle; Cécile Bracq; Philippe Dreyfus; Philippe Nouguier; Antoine Gache; Claude Meurisse; Bertrand Boulanger; Claude Lae; Jacques Metzger; Valérie Raphael; Arielle Beruben; Volker Wenzel; Comlavi Guinhouya; Christian Vilhelm; Emmanuel Marret
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

8.  Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.

Authors:  Spyros D Mentzelopoulos; Spyros G Zakynthinos; Maria Tzoufi; Nikos Katsios; Androula Papastylianou; Sotiria Gkisioti; Anastasios Stathopoulos; Androniki Kollintza; Elissavet Stamataki; Charis Roussos
Journal:  Arch Intern Med       Date:  2009-01-12

9.  Frequency and outcome of in-hospital resuscitation outside the ICU-setting.

Authors:  Alain Rudiger; Daniel Tobler; Werner Estlinbaum
Journal:  Swiss Med Wkly       Date:  2004-01-24       Impact factor: 2.193

10.  Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical services for patients with out of hospital cardiac arrest in Japan: controlled propensity matched retrospective cohort study.

Authors:  Shinji Nakahara; Jun Tomio; Hideto Takahashi; Masao Ichikawa; Masamichi Nishida; Naoto Morimura; Tetsuya Sakamoto
Journal:  BMJ       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.